Skip to search formSkip to main contentSkip to account menu

Millimole per Mole

Known as: mmol/mol 
A unit of fraction expressed as the ratio of the amount of substance of solute in millimoles to the amount of substance of the mixture in moles.
National Institutes of Health

Related topics

Related topics

1 relation
Clinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes
Objective Nutrition therapy is an integral part of self-management education in patients with type 2 diabetes. Carbohydrates with… 
Highly Cited
2016
Highly Cited
2016
Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders
OBJECTIVE Type 2 diabetes mellitus (T2DM) is generally regarded as an irreversible chronic condition. Because a very low-calorie… 
Highly Cited
2016
Highly Cited
2016
Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial
Aims/hypothesisMounting evidence indicates that Roux-en-Y gastric bypass (RYGB) ameliorates type 2 diabetes, but randomised… 
Highly Cited
2016
Highly Cited
2016
Kindness Matters: A Randomized Controlled Trial of a Mindful Self-Compassion Intervention Improves Depression, Distress, and HbA1c Among Patients With Diabetes
OBJECTIVE Mood difficulties are common among patients with diabetes and are linked to poor blood glucose control and increased… 
Highly Cited
2015
Highly Cited
2015
Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison
Improving glycaemic control in people with Type 1 diabetes is known to reduce complications. Our aim was to compare glycaemic… 
Highly Cited
2015
Highly Cited
2015
Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes
BackgroundThe aim of the study was to evaluate the effect of delay in treatment intensification (IT; clinical inertia) in… 
Highly Cited
2014
Highly Cited
2014
Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)
OBJECTIVE Compare the efficacy and safety of monotherapy with dulaglutide, a once-weekly GLP-1 receptor agonist, to metformin… 
Highly Cited
2014
Highly Cited
2014
Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5)
OBJECTIVE To compare the efficacy and safety of two doses of once-weekly dulaglutide, a glucagon-like peptide 1 receptor agonist… 
Highly Cited
2014
Highly Cited
2014
Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial
OBJECTIVE To compare effects of combinations of standard and intensive treatment of glycemia and either blood pressure (BP) or… 
Highly Cited
2012
Highly Cited
2012
The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial
Aims/hypothesisThe aim of this multicentre, randomised, controlled crossover study was to determine the efficacy of adding… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)